Approaching treatment for hepatitis C virus infection in substance users

Clinical Infectious Diseases

Volumn 41, Issue 1 SUPPL., 2005, Pages

  Sylvestre, Diana L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 20844454547     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429501     Document Type: Article

References (11)

1. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(Suppl 1):S6-10.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-82.
4. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
5. Backmund M, Meyer K, Von Zielonka M, Eichenlaub D. Treatment of hepatitis C infection in injection drug users. Hepatology 2001; 34: 188-93.
6. Dalgard O, Bjoro K, Hellum K, et al. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Eur Addict Res 2002; 8: 45-9.
7. Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN. The impact of barriers to HCV treatment in recovering heroin users maintained on methadone. J Subst Abuse Treat (in press).
8. Sylvestre DL. Treating hepatitis C virus in active substance users. Clin Infect Dis 2005;40(Suppl 5)S321-4.
9. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-92.
10. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998; 352:1426-32.
11. McCance-Katz EF, Rainey PM, Smith P, et al. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir. Am J Addict 2004; 13:163-80.